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The fate of the three environmentally relevant b-blockers atenolol, metoprolol and propranolol has been
studied in batch experiments involving aquifer material and nitrate reducing conditions. Results from the
about 90 d long tests indicate that abiotic processes, most likely sorption, jointly with biotransformation
to atenololic acid were responsible for the 65% overall removal observed for atenolol. Zero order kinetics,
typical of enzyme-limited reactions, controlled the transformation of this beta blocker to its correspond-
ing carboxylic acid. The mass balance evidences that no mineralization of atenolol occurs in the biotic
experiment and that atenololic acid is more stable than its parent compound under the studied condi-
tions. This finding stresses the importance of considering atenololic acid as target compound in the envi-
ronmental studies on the fate of atenolol. For metoprolol and propranolol the results from the experiment
suggest a slower sorption to be the dominant removal process, which led to final decreases in concentra-
tions of 25–30% and 40–45%, respectively. Overall, the removals observed in the experiments suggest that
subsurface processes potentially constitute an alternative water treatment for the target beta-blockers,
when compared to the removals reported for conventional wastewater treatment plants.
 2012 Elsevier Ltd. All rights reserved.1. Introduction
Beta-blockers (b-adrenergic receptor antagonists) are a class of
widely prescribed cardiovascular drugs, used for the treatment of
hypertension, cardiac arrhythmias, cardio protection after heart at-
tacks, and anxiety disorders. After excretion, substantial amounts
of these drugs get into the wastewater and end up in sewage treat-
ment plants. Conventional wastewater treatments cannot remove
them efficiently (Lin et al., 2009; Radjenovic et al., 2009; Gabet-
Giraud et al., 2010; Gros et al., 2010). Therefore, b-blockers are dis-
charged into surface waters, where indeed they have been detected
at concentrations ranging from ng L1 to lg L1 (Kasprzyk-Hordern
et al., 2008; Muñoz et al., 2009; Martínez Bueno et al., 2010; Nödlerll rights reserved.
.
. Barbieri).et al., 2011). Ecotoxicological studies reported b-blockers to affect
the aquatic organisms, propranolol being the most harmful one
(Fent et al., 2006; Küster et al., 2009). Several studies have thus
been devoted to foster the understanding of their behaviour in
aquatic-sediment systems. Such studies focus on phototransforma-
tion, aerobic biotransformation and sorption to river sediments
rich in organic carbon (Andreozzi et al., 2003; Liu and Williams,
2007; Yamamoto et al., 2009; Ramil et al., 2010). However, infor-
mation on their fate in subsurface environments, especially under
reducing conditions, is still scarce. Kibbey et al. (2007) studied the
adsorption of nadolol, metoprolol and propranolol to a natural
alluvial material, as well as to six individual mineral subcompo-
nents of the sediments in batch experiments. Their results sug-
gested that hydrophobicity serves as a predictor of adsorption
even to low carbon sorbents, with propranolol, the most hydropho-
bic compound studied, adsorbing to the greatest extent. At river
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removals of up to more than 70% for atenolol, metoprolol, bisopro-
lol and sotalol under redox conditions varying from aerobic to
strictly anaerobic. Finally, Ternes et al. (2007) reported complete
elimination of atenolol, celiprolol, metoprolol, propranolol, and
sotalol under unspecified redox conditions during irrigation of an
agricultural field with secondary treated sewage, and attributed
the removal to biodegradation rather than to sorption.
In this context, and motivated by a managed artificial recharge
pond project in the Llobregat River (Barcelona, Spain), we studied
the behaviour of three environmentally relevant b-blockers ateno-
lol, metoprolol and propranolol in aquifer material under nitrate
reducing conditions. Results from the batch experiments per-
formed are reported in the present paper.2. Materials and methods
The set up was based on microcosms containing natural sedi-
ments, synthetic water and a mixture of organic pollutants at indi-
vidual initial concentrations of 1 mg L1. The experiment included
biotic and abiotic series to identify the effect of microbial activity.
Nitrate reducing conditions were stimulated in the biotic series by
adding easily degradable organic compounds as electron donors
(sodium acetate and methanol), and an excess of nitrate as specific
electron acceptor.2.1. Materials and experimental procedure
Sediments were obtained from a test site for artificial recharge
of groundwater through ponds located in Sant Vicenç dels Horts
(Barcelona, Spain). The aquifer consists of quaternary alluvial sed-
iments, mainly gravel and sand with a small fraction of clay. Sam-
ples were collected from an oxic unsaturated horizon at about 1 m
depth under the bottom of the infiltration pond, prior to the start of
water recharge operations. They were sieved to <1 mm and imme-
diately used for assembling the experiments. Their mineralogical
and chemical analysis revealed the presence of silicates, carbonates
(calcite, dolomite), and some Mn(IV)/Mn(III) and Fe(III) oxides and
oxide–hydroxides (associated content of Mn and Fe: 0.07 and
5.8 mg g1 of air dried sediment, respectively). The fraction with
grain size <4 lm ranged between 2% and 6%. Total carbon content
was 2.5%, with an organic carbon and nitrogen content smaller
than 0.2%.
Experiment water was artificially prepared based on the chem-
ical composition of the recharge water (Llobregat river water) at
the test site. Magnesium nitrate hexahydrate was used to add
66 mmol L1 of NO3 . The resulting water was purged with argon
during 1 h to remove dissolved oxygen. Concentrations (mmol L1)
of cations and anions were as follows: 7.8 (Na), 1.0 (K), 3.0 (Ca),
34.3 (Mg), 12.8 (Cl), 66.1 (NO3 ), 2.1 (SO
2
4 ), 0.5 (Alk), 0.1 (NH
þ
4 ),
and 0.02 (PO34 ). No dissolved organic carbon (DOC) was present
in solution at this stage.
Atenolol, metoprolol and propranolol were added to the water
by the use of a spiking solution. Atenolol and propranolol were
purchased from Fagron (Barsbüttel, Germany), and metoprolol
from Sigma–Aldrich (Steinheim, Germany). Atenololic acid was
purchased from LGC Promochem (Wesel, Germany). The internal
standards (IS) atenolol-D7 and metoprolol-D7 were also purchased
from Sigma–Aldrich. Individual stock solutions of the analytes
were prepared by dissolving each compound in methanol. Working
standard mixtures were then prepared at different concentrations
by further dilution of the individual stock solutions in methanol, to
be used as spiking solution and to prepare the aqueous calibration
standards (Section 2.2). Stock and working standard solutions werestored at 18 C in the dark. The physicochemical characteristics of
the three selected b-blockers are shown in Table 1.
The assembling of the batches was carried out inside a glove
box, under argon (Ar) atmosphere. The ‘‘initial water’’ was ob-
tained by adding 2.1 mmol of anhydrous sodium acetate and
3 mL of spiking solution (0.333 mg of each pollutant per mL meth-
anol) per L of the synthetic water, yielding an analytical initial DOC
of 71.5 mmol L1 and a concentration of 1 mg L1 for each organic
pollutant. After sampling the solution for chemical analyses, the
microcosms were prepared by filling 0.3 L glass bottles with
120 g of air-dried homogenized sediments, and 240 mL of ‘‘initial
water’’. Assembling was concluded by properly sealing the bottles
against oxygen with screw-caps plus a PTFE protection seal, and
gently shaking. A remaining headspace of 15 mL was left in each
bottle. Batches were then removed from the glove box, wrapped
in aluminium foil to prevent photodegradation, and incubated at
25 ± 2 C. On a regular basis, they were gently shaken.
For the abiotic tests, both synthetic water and sediments were
sterilized prior to assembling. They were introduced three times
(once a day in three consecutive days) into an autoclave at
T = 121 C and P = Patm + 1 atm for 20 min. The glove box was ster-
ilized with UV light before introducing the materials. As an addi-
tional precaution, 0.22 mmol L1 of mercury chloride were added
(as microbial poison) to the ‘‘initial water’’.
Duplicate bottles were sacrificed according to a pre-defined
schedule (at days 2, 5, 10, 15, 25, 41 and 87). One at a time, the
two bottles were opened under Ar atmosphere, chemical parame-
ters were measured, and aqueous samples for the analysis of the
general chemistry and b-blockers were collected and stored
according to laboratory recommendations until analysis. The ste-
rility of the abiotic series was verified twice during the full dura-
tion of the tests. To this aim, an aliquot of water from selected
samples was spread on tryptic soy agar (TSA) plates and incubated
in duplicate at 25 C under aerobic conditions (during 1 week) and
anaerobic conditions (during 2 weeks). None of the plates dis-
played microorganisms’ growth.
2.2. Analytical methods
Biotic samples collected during microcosms’ assembling/disas-
sembling for analysing Cl, NO3 , NO

2 , SO
2
4 , PO
3
4 , F
, NHþ4 and dis-
solved organic carbon (DOC) were filtered through 0.45 lm PALL
Acrodisc Sterile Syringe Filters with Supor membrane and fro-
zen. Anions were analysed by ion chromatography using an ICS-
1000 instrument. The analytical error was estimated to be 14%
for PO34 and 13% for the remaining anions. NH
þ
4 concentration
was analysed with a selective electrode Orion 9512. DOC was ana-
lysed by 680 C combustion catalytic oxidation/NDIR method using
a TOC-V CSH instrument. The estimated analytical error was 20%.
Biotic and abiotic samples for analysing chemical oxygen demand
(COD) were also filtered 0.45 lm and frozen, to be further analysed
by colorimetry with the Spectroquant Nova 60 spectrophotometer.
Abiotic samples for Cl, NO3 , SO
2
4 and F
 were frozen and then
analysed by ion chromatography using a Dionex DX-320 instru-
ment with conductometric detection, a Dionex AS11-HC
(2  250 mm) column and 23 mM KOH as eluent (isocratic separa-
tion at 30 C). A flow rate of 0.38 mL min1 was applied. Prior to
chromatography, samples were filtered (Whatman Anotop 10 IC,
0.2 lm). The analytical error was estimated to be 8%.
Samples for Fe and Mn, Ca, Mg, Na, K and minor elements were
also filtered at 0.45 lm, acidified and stored at 4 C. They were la-
ter analysed by inductively coupled plasma atomic emission spec-
trometry (ICP-AES) using a Thermo Jarrel-Ash Iris Advantage HS
instrument. Detection limits were 100 lg L1 for K and Na, and
50 lg L1 for the rest. The analytical error was estimated below
3%. In the ICP-AES analyses, calibration with three laboratory sets
Table 1
Physicochemical properties of the target b-blockers.
Compound Structure CAS number logKowa pkaa Formula
Atenolol O
H2N
O NH
OH
29122-68-7 0.1 ± 0.28 9.2 ± 0.4 C14H22N2O3
Metoprolol
OH
O
O
NH
37350-58-6 1.79 ± 0.4 9.2 ± 0.4 C15H25NO3
Propranolol
HO
O
N
H
525-66-6 3.48b 9.42b C16H21NO2
a SciFinder predicted values (unless otherwise noted), predominantly positively charged at typical groundwater pH 7.
b From SRC database.
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ficients of the calibration curves exceeded 0.999.
Temperature and pH (Thermo Scientific 9157BN Triode pH elec-
trode, refillable), electrical conductivity (Hanna Instruments,
76302W conductivity probe), dissolved oxygen (Hanna Instru-
ments, HI 76407/4 DO probe) and alkalinity (drop test kit Taylor
K-1726, precision of 0.5 mmol L1) were measured during the
assembling/disassembling procedure.
Samples for the analysis of b-blockers were kept frozen until
analysis. Atenolol and metoprolol were quantified without precon-
centration by an HPLC/ESI-MS–MS method as described by Nödler
et al. (2010). The individual MS–MS parameters of atenololic acid,
propranolol and metoprolol-D7 were as follows: for atenololic acid,
the quantifier and qualifier transitions in positive electrospray
(+ESI) were 268? 145 and 268? 191, respectively. The respective
collision energieswere17.5 V and12 V, and the capillary voltage
was set to 60 V. For propranolol, the quantifier and qualifier transi-
tions in +ESI were 260? 116 and 260? 183, respectively. The ap-
plied collision energy was 8.5 V for both transitions and the
capillary voltage was set to 55 V. For metoprolol-D7, the quantifier
transition in +ESI was 275? 123, the applied collision energy was
11.5 V, and the capillary voltage was 55 V. Prior to analysis, the
sampleswere diluted (v/v) 1:2with aqueous 5 mMammoniumace-
tate solution, containing 4%methanol. Atenolol-D7 was used for the
quantification of atenolol and propranolol. Metoprolol-D7 was used
for that of metoprolol. 100 ng mL1 of each IS was added. For addi-
tionalmatrix compensation, calibration standards were prepared in
inorganic matrix according to 50% of the experimental water con-
centration. Before analysis, all samples and standard solutions were
centrifuged at 1500 rpm (Christ RVC 2-18, purchased from Fisher
Scientific, Schwerte, Germany) for 30 min at room temperature.
Six concentration levels (1-500 ng mL1) were used for the calibra-
tion and the correlation coefficients exceeded 0.99.Fig. 1. Evolution of bulk water chemistry in the biotic experiment.3. Discussion of results
Results are presented below in terms of averages of data from
the duplicate batches. For the organic pollutants, concentrations
are presented in relative terms (C/C0, where C0 is the measured ini-
tial concentration) in order to remove systematic errors from the
analyses. Error bars were calculated by combining the analytical
errors and the difference between results of duplicate batches.3.1. Bulk water chemistry
The chemical evolution of the main water chemistry in the bio-
tic experiment is presented in Fig. 1. Results from duplicate
batches showed a satisfactory reproducibility at all sampling times.
When plotting the data plus the error bars from each batch, there
was always some overlap. Thus, only the average of results from
the duplicate bottles is reported in the figure.
DOC and nitrate decreased over the whole experiment, starting
(appreciably) after day 5 and being still present at day 87 with final
concentrations of 27.2 mmol L1 and 7.5 mmol L1, respectively.
Alkalinity increased continuously after day 2, from 0.8 mmol L1
to 22 mmol L1. Dissolved oxygen was not detected at any time.
Nitrite was already detectable at day 2 but its concentration only
began to increase appreciably after 2 d, reaching its maximum at
day 41 and becoming completely depleted by day 87. Dissolved
manganese and iron were not detected, sulphate remained con-
stant throughout the experiment (results not shown), and pH ran-
ged between 7.3 and 8.3.
The previous observations, consistent with the expected evolu-
tion of the redox sensitive species, suggest that nitrate reducing
conditions were established within less than 2 d of microbial
adaptation, and dominated the system during the whole test. The
occurrence of nitrite reflects the actual denitrification pathway,
with nitrite being an intermediate product between nitrate and
nitrogen. Its depletion between day 41 and 87, when nitrate
Fig. 3. Evolution of metoprolol average concentration (normalized to the initial
concentration Co) during the biotic experiment and its abiotic control.
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toward nitrogen being faster than the production of nitrite from ni-
trate during this time.
Quantitative consistency of the expected degradation processes
was checked by a mass balance of electrons and major elements.
Assuming that the only process that can change nitrate concentra-
tion was reduction caused by the oxidation of organic matter (i.e.
acetate and methanol in the present experiment), we considered
the overall stoichiometries:
CH3OHþ 1:2NO3 þ 0:2Hþ ! HCO3 þ 0:6N2
þ 1:6H2O ðReaction 1Þ
CH3COO
 þ 1:6NO3 þ 0:6Hþ ! 2HCO3 þ 0:8N2
þ 0:8H2O ðReaction 2Þ
plus an additional reaction:
CH3OHþ 0:4NO3 þ 0:4Hþ
! CH2Oþ 0:2N2 þ 1:2H2O ðReaction 3Þ
which takes into account that in the case of methanol (oxidation
number of carbon = 2) the formation of biomass (CH2O used as a
simplified formula) requires a partial oxidation (bulk biomass has
a redox state of 0). By using such reactions, it was calculated that
5–10% of the organic carbon consumed during the experiment
was converted into biomass, while the remaining part was mineral-
ized. By the overall measured decrease of calcium and magnesium
(not shown) it was then estimated that about 24.3 mmol L1 of
the generated inorganic carbon precipitated as carbonates.
Accounting for inorganic carbon transfer to the gas phase in the
headspace of the bottles, alkalinity build up and precision of alka-
linity measurements, the overall inorganic carbon mass balance
could be finally closed with an error of about 10%.
Regarding the abiotic experiment, hydrochemistry remained
practically constant for the whole time, as expected (results not
shown).
3.2. Fate of the selected b-blockers
3.2.1. Fate of atenolol and metoprolol
Results for atenolol in the biotic and abiotic control series (Fig. 2)
display a similar trend during the first 5–10 d, suggesting that the
initial disappearance of atenolol (of about 14%) was dominated by
abiotic processes. This abiotic removal can be attributed to sorption
affinity e.g. on the negative charged surface of clayminerals because
atenolol, with a pKa of 9.2, is predominantly positively charged in
the pH range of these experiments. Taking into account the error
bars, no further removal could be observed in the abiotic series after
day 10. Since atenolol logKow is very low (0.1), no additional
sorption onto biofilm should be expected during the biotic
experiment. From day 10 on, therefore, the removal of atenolol inFig. 2. Evolution of atenolol average concentration (normalized to the initial
concentration Co) during the biotic experiment and its abiotic control.the denitrifying series must be related to microbial activity. Only
35%of the initial atenololwas left at the end of the biotic experiment
(day 87).
To better understand the fate of atenolol, all samples were ana-
lysed for atenololic acid. This acid was identified by Radjenovic
et al. (2008) as a microbial transformation product of atenolol, gen-
erated by hydrolysis of its amide bond. Indeed, atenololic acid could
bedetected in ourmicrocosms. The fact that it could only be found in
water from the biotic series confirmed the relationship of its forma-
tion with microbial processes. Actually the human and animal
metabolite of metoprolol, metoprolol acid, is identical to atenololic
acid (Lennard, 1985and references therein; Fang et al., 2004). There-
fore, it might be conjectured that the observed atenololic acid in our
samples results from the biotransformation of both atenolol and
metoprolol. However, the evolution of metoprolol in the biotic and
abiotic series (Fig. 3) suggests abiotic processes to be responsible
of the overall removal of this compound, of 25–30% at day 87. Thus,
no biotransformation of metoprolol occurred in our tests and the
atenololic acid solely originates from atenolol transformation.
The time evolutions of the concentrations of atenolol and ate-
nololic acid are presented together in Fig. 4. In order to close the
mass balance of atenolol in the biotic experiment we also plot
the sum of the two compounds.
By the plot it could be observed that, even if some atenololic
acid was already being formed, the sum of the two concentrations
decreases during the first 10 d of the biotic experiment, most likely
reflecting the predominance of atenolol sorption during this peri-
od. Afterwards, the sum remains constant, i.e. the amount of
atenolol disappearing is consistent with atenololic acid build-up.
Therefore, we conclude that from day 10 up to day 87 of the bioticFig. 4. Evolution of atenolol (blue), atenololic acid (purple) and the sum (red)
concentrations with time. Symbols indicate sampling times and lines are plot for
visualization aid. Concentrations are expressed as lmol L1. (For interpretation of
the references to colour in this figure legend, the reader is referred to the web
version of this article.)
Fig. 5. Evolution of propranolol average concentration (normalized to the initial
concentration Co) during the biotic experiment and its abiotic control.
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nantly being biotransformed to atenololic acid. Overall, the mass
balance evidences no mineralization of atenolol during the whole
experiment and the formed atenololic acid is stable under the con-
ditions studied.
The likelihood of the process of amide hydrolysis, leading to the
production of atenolol corresponding carboxylic acid, is consistent
with the findings of Radjenovic et al. (2008), who performed bio-
degradation tests in aerated batch reactors using sewage sludge
as inoculum. In a study on several amide-containing compounds,
Helbling et al. (2010) observed hydrolysis to be a preferential bio-
transformation pathway for primary amides and also confirmed
atenolol to be hydrolysed to atenololic acid. They furthermore pro-
posed a mechanism for such enzyme-catalysed reaction, indicating
amidases and proteolytic enzyme as the catalysts possibly in-
volved. Such enzymes are ubiquitous in nature, and could obtain
a quite high bioconversion yield by reactions involving C–N
bond-containing substrates like amides (Fournand and Arnaud,
2001; Sharma et al., 2009).
It is worth mentioning that the arithmetic scale evolution of
atenolol in the biotic series is virtually linear (removal rate of
0.021 lmol L1 d1) after day 5–10 (Fig. 4). Such a zero order ki-
netic law indicates that the removal of atenolol associated to bio-
activity was controlled by factors other than nitrate, DOC or
atenolol concentration. The evolution of atenololic acid exhibited
also a linear trend (Fig. 4), similar and opposite in sign to that of
atenolol. A production rate of 0.021 lmol L1 d1 could be esti-
mated, matching the rate of atenolol removal. In light of the micro-
bial nature of the process, the observed zero order kinetics could be
explained by an enzyme-limited transformation of atenolol to ate-
nololic acid, i.e. a biotransformation in which the enzyme concen-
tration represented the rate-limiting factor.3.2.2. Fate of propranolol
The evolution of propranolol in the biotic and abiotic series
(Fig. 5) presented almost the same trend over time. This implies
that some slow abiotic process dominated the concentration de-
cline for this compound, leading to an overall removal of 40–45%
at day 87. We conjecture that it can be attributed to sorption affin-
ity, e.g. of the cationic portion of propranolol on the negatively
charged surface of clay minerals and of the neutral portion of the
compound onto the small amount of organic matter existing in
the sediments (pKa 9.42, pH during the experiments between 7.3
and 8.3, and a significant logKow of 3.48).4. Conclusions
Results from the about 90 d long batch experiments involving
aquifer material and characterised by denitrifying conditions indi-
cate that:– Abiotic processes, most likely sorption of the positively charged
species to clay minerals, dominated the first 5–10 d of the
experiment in the case of atenolol, yielding a removal of about
14%. This beta blocker exhibited also an additional bioactivity-
related removal in the biotic series. A total of 65% of atenolol
has disappeared in such experiment by day 87.
– The detection of atenololic acid in the biotic, but not in the abi-
otic, series suggests that atenolol is biotransformed during the
denitrifying experiment by hydrolysis of its amide bond,
according to the mechanism proposed by Radjenovic et al.
(2008). The temporal evolution of the concentration of both
compounds reflects zero order kinetics, likely indicating an
enzyme-limited biotransformation of atenolol into its corre-
sponding carboxylic acid. It is relevant to notice that overall
the mass balance evidences no measurable mineralization of
atenolol during the whole experiment. In fact, its transforma-
tion product atenololic acid appears to be stable under the stud-
ied conditions, as it does not appear to be degraded nor sorb
onto either minerals or biofilms. This finding stresses the
importance of including atenololic acid as target compound in
environmental studies on the fate of atenolol.
– There was no evidence for biotransformation or biologically
mediated removal of metoprolol and propranolol. Some slow
abiotic processes were responsible of the concentration decline
for these blood pressure regulators, leading to overall removals
of 25–30% and 40–45%, respectively, by day 87. Beside a poten-
tial sorption of the cationic species of both compounds e.g. to
clay minerals, the higher removal observed for propranolol
could be likely explained by a higher sorption affinity of its neu-
tral species to the small amount of organic matter present in the
sediments. Indeed, propranolol logKow (3.48) is significantly
higher than the respective logKow of the two other target
beta-blockers, atenolol and metoprolol.
It has to be added that the average removal reported for the
three target b-blockers in conventional wastewater treatments
plants ranges from 58% to 80% for atenolol, 20–40% for metoprolol,
and 20–60% for propranolol (Lin et al., 2009; Radjenovic et al.,
2009; Gabet-Giraud et al., 2010; Gros et al., 2010). These are com-
parable to the overall removals observed in our experiments (i.e.
approximately 65% removal for atenolol, 25–30% for metoprolol,
and 40–45% for propranolol). Therefore, we conclude that aquifer
processes constitute an alternative water treatment for the studied
beta-blockers. These processes can lead to similar or even higher
elimination percentages than conventional wastewater treat-
ments. The longer time needed to reach such removals may be en-
sured by the long residence times in aquifers. Further investigation
is needed to confirm these findings at lower concentrations of the
target pollutants.Acknowledgements
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